# A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

> **NCT06854341** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 5448 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06854341
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-09
- **Primary completion:** 2024-08-27
- **Final completion:** 2024-08-27
- **Target enrollment:** 5448 (ACTUAL)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854341, "A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06854341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*